Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss EBS - Emergent BioSolutions Inc.
-5.7 M
LAST VALUE
40.50%
2 YEAR CAGR
-0.72%
5 YEAR CAGR
-5.10%
10 YEAR CAGR